DAPSONE

DAPSONE was reported 10864 times

These side effects are most commonly reported by patients taking DAPSONE:

# Side effect Count
0 OFF LABEL USE 1306
1 DRUG INEFFECTIVE 1166
2 METHAEMOGLOBINAEMIA 498
3 NAUSEA 492
4 FATIGUE 487
5 PYREXIA 474
6 DIARRHOEA 426
7 RASH 405
8 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 399
9 DYSPNOEA 392
10 PNEUMONIA 385
11 PAIN 376
12 ANAEMIA 374
13 CONDITION AGGRAVATED 366
14 TREATMENT FAILURE 364
15 PRODUCT USE IN UNAPPROVED INDICATION 351
16 HEADACHE 308
17 VOMITING 293
18 ASTHENIA 291
19 ACUTE KIDNEY INJURY 245
20 PRURITUS 241
21 DEATH 238
22 SEPSIS 235
23 RENAL FAILURE 233
24 DIZZINESS 225
25 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 212
26 ANXIETY 206
27 DRUG INTERACTION 198
28 THROMBOCYTOPENIA 197
29 HYPERTENSION 195
30 MALAISE 192
31 ERYTHEMA 191
32 WEIGHT DECREASED 183
33 ABDOMINAL PAIN 179
34 HYPOTENSION 178
35 COUGH 176
36 NEUTROPENIA 173
37 HAEMOLYTIC ANAEMIA 171
38 URTICARIA 170
39 ARTHRALGIA 168
40 PRODUCT DOSE OMISSION ISSUE 166
41 PANCYTOPENIA 163
42 DRUG HYPERSENSITIVITY 159
43 DEPRESSION 158
44 EMOTIONAL DISTRESS 156
45 WEIGHT INCREASED 154
46 CHRONIC KIDNEY DISEASE 140
47 DECREASED APPETITE 139
48 HYPOXIA 138
49 PLATELET COUNT DECREASED 138
50 BLOOD CREATININE INCREASED 136
51 CONSTIPATION 136
52 FALL 136
53 RENAL IMPAIRMENT 135
54 HAEMOGLOBIN DECREASED 131
55 WHITE BLOOD CELL COUNT DECREASED 130
56 THERAPY NON-RESPONDER 129
57 DRUG INTOLERANCE 126
58 FEBRILE NEUTROPENIA 126
59 OEDEMA PERIPHERAL 125
60 DISEASE PROGRESSION 124
61 INFECTION 122
62 NEUROPATHY PERIPHERAL 122
63 RESPIRATORY FAILURE 121
64 SKIN EXFOLIATION 121
65 INTENTIONAL PRODUCT USE ISSUE 119
66 BACK PAIN 118
67 OXYGEN SATURATION DECREASED 115
68 DEHYDRATION 113
69 CHEST PAIN 112
70 INSOMNIA 112
71 CHILLS 111
72 CONFUSIONAL STATE 111
73 NO ADVERSE EVENT 111
74 ANGIOEDEMA 107
75 BLOOD PRESSURE INCREASED 107
76 FEELING ABNORMAL 107
77 ANHEDONIA 106
78 MUSCLE SPASMS 105
79 ACNE 104
80 HYPERSENSITIVITY 104
81 PRODUCT USE ISSUE 104
82 URINARY TRACT INFECTION 103
83 DRUG-INDUCED LIVER INJURY 102
84 LEUKOPENIA 99
85 PAIN IN EXTREMITY 98
86 PULMONARY EMBOLISM 96
87 DISEASE RECURRENCE 95
88 MYALGIA 95
89 PERIPHERAL SWELLING 92
90 GAIT DISTURBANCE 91
91 OSTEOPOROSIS 88
92 BLISTER 87
93 DEEP VEIN THROMBOSIS 86
94 COVID-19 85
95 HAEMOLYSIS 85
96 TOXICITY TO VARIOUS AGENTS 83
97 DRY SKIN 81
98 TREMOR 80
99 CATARACT 77
100 MUSCULAR WEAKNESS 77
101 ADVERSE DRUG REACTION 76
102 CELLULITIS 76
103 SKIN LESION 76
104 VISION BLURRED 76
105 ALOPECIA 75
106 HYPOAESTHESIA 75
107 RENAL FAILURE ACUTE 75
108 ABDOMINAL DISCOMFORT 74
109 NASOPHARYNGITIS 74
110 SINUSITIS 74
111 CYTOMEGALOVIRUS INFECTION 73
112 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 73
113 LETHARGY 73
114 PLEURAL EFFUSION 73
115 SOMNOLENCE 73
116 PARAESTHESIA 72
117 GENERAL PHYSICAL HEALTH DETERIORATION 71
118 GASTROINTESTINAL DISORDER 70
119 PRODUCT QUALITY ISSUE 70
120 REBOUND EFFECT 70
121 STAPHYLOCOCCAL INFECTION 70
122 UPPER RESPIRATORY TRACT INFECTION 70
123 ABDOMINAL PAIN UPPER 69
124 HOSPITALISATION 69
125 TACHYCARDIA 69
126 ASPARTATE AMINOTRANSFERASE INCREASED 67
127 RASH ERYTHEMATOUS 67
128 END STAGE RENAL DISEASE 65
129 INFLUENZA 65
130 PEMPHIGOID 65
131 ALANINE AMINOTRANSFERASE INCREASED 64
132 ECONOMIC PROBLEM 63
133 LINEAR IGA DISEASE 63
134 RASH MACULO-PAPULAR 63
135 SEPTIC SHOCK 62
136 THERAPY PARTIAL RESPONDER 62
137 DIABETES MELLITUS 61
138 OSTEONECROSIS 61
139 RASH PRURITIC 61
140 SKIN DISCOLOURATION 61
141 JAUNDICE 60
142 LYMPHADENOPATHY 60
143 TREATMENT NONCOMPLIANCE 60
144 ATRIAL FIBRILLATION 59
145 BONE MARROW FAILURE 59
146 BRONCHITIS 59
147 PALPITATIONS 59
148 PRODUCT DELIVERY MECHANISM ISSUE 59
149 HIDRADENITIS 58
150 PLASMA CELL MYELOMA 58
151 ASTHMA 57
152 BLOOD GLUCOSE INCREASED 57
153 CONTUSION 57
154 LOSS OF CONSCIOUSNESS 57
155 SWELLING 57
156 MENTAL DISORDER 56
157 MOBILITY DECREASED 56
158 THROMBOSIS 56
159 ACUTE RESPIRATORY FAILURE 55
160 HERPES ZOSTER 55
161 THERAPEUTIC RESPONSE DECREASED 55
162 CYANOSIS 54
163 DRUG DOSE OMISSION 54
164 PYODERMA GANGRENOSUM 54
165 DYSPHAGIA 53
166 BLOOD BILIRUBIN INCREASED 52
167 CEREBROVASCULAR ACCIDENT 52
168 GASTROOESOPHAGEAL REFLUX DISEASE 52
169 HYPERKALAEMIA 52
170 MENTAL STATUS CHANGES 52
171 SWELLING FACE 52
172 BURNING SENSATION 51
173 PNEUMOCYSTIS JIROVECII PNEUMONIA 51
174 PSEUDOMONAS INFECTION 51
175 HEPATIC ENZYME INCREASED 50
176 OSTEOPENIA 50
177 RED BLOOD CELL COUNT DECREASED 50
178 SKIN DISORDER 50
179 ABDOMINAL DISTENSION 49
180 CARDIAC FAILURE 49
181 GRAFT VERSUS HOST DISEASE 49
182 HEPATITIS 49
183 OEDEMA 49
184 SUICIDAL IDEATION 49
185 TYPE 2 LEPRA REACTION 49
186 INJECTION SITE REACTION 48
187 MYOCARDIAL INFARCTION 48
188 SYNCOPE 48
189 CLOSTRIDIUM DIFFICILE INFECTION 47
190 SEROTONIN SYNDROME 47
191 SKIN IRRITATION 47
192 BLOOD PRESSURE SYSTOLIC INCREASED 46
193 DRUG RESISTANCE 46
194 HEPATIC FAILURE 46
195 LEUKOCYTOSIS 46
196 MEMORY IMPAIRMENT 46
197 NEUTROPHIL COUNT DECREASED 46
198 WHITE BLOOD CELL COUNT INCREASED 46
199 ANAPHYLACTIC REACTION 45
200 DERMATITIS 45
201 HAEMORRHAGE 45
202 LIVER FUNCTION TEST ABNORMAL 45
203 PRODUCTIVE COUGH 45
204 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 45
205 VISUAL IMPAIRMENT 45
206 CARDIAC ARREST 44
207 HEART RATE INCREASED 44
208 ILLNESS 44
209 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 44
210 GASTROINTESTINAL HAEMORRHAGE 43
211 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 43
212 INTENTIONAL OVERDOSE 43
213 MULTIPLE ORGAN DYSFUNCTION SYNDROME 43
214 MYOPATHY 43
215 STEVENS-JOHNSON SYNDROME 43
216 HYDRONEPHROSIS 42
217 HYPERGLYCAEMIA 42
218 LUNG DISORDER 42
219 OROPHARYNGEAL PAIN 42
220 SYSTEMIC LUPUS ERYTHEMATOSUS 42
221 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 41
222 FUNGAL INFECTION 41
223 JOINT SWELLING 41
224 METABOLIC ACIDOSIS 41
225 RASH MACULAR 41
226 RESPIRATORY DISTRESS 41
227 STRESS 41
228 ULCER 41
229 DELIRIUM 40
230 LUNG INFILTRATION 40
231 SKIN ULCER 40
232 AMNESIA 39
233 BLOOD ALKALINE PHOSPHATASE INCREASED 39
234 CUSHINGOID 39
235 DYSPNOEA EXERTIONAL 39
236 HYPERHIDROSIS 39
237 INFUSION RELATED REACTION 39
238 INJECTION SITE PAIN 39
239 NOCARDIOSIS 39
240 TYPE 1 DIABETES MELLITUS 39
241 IMPAIRED HEALING 38
242 MUSCULOSKELETAL STIFFNESS 38
243 BALANCE DISORDER 37
244 CHEST DISCOMFORT 37
245 EPISTAXIS 37
246 HYPONATRAEMIA 37
247 LABORATORY TEST ABNORMAL 37
248 MIGRAINE 37
249 NIGHT SWEATS 37
250 ORAL CANDIDIASIS 37
251 PNEUMONITIS 37
252 CLOSTRIDIUM DIFFICILE COLITIS 36
253 ENCEPHALOPATHY 36
254 INFLUENZA LIKE ILLNESS 36
255 PANCREATITIS 36
256 PRODUCT SUBSTITUTION ISSUE 36
257 PULMONARY OEDEMA 36
258 RENAL DISORDER 36
259 SKIN BURNING SENSATION 36
260 BLOOD PRESSURE DECREASED 35
261 BONE DENSITY DECREASED 35
262 CARDIAC FAILURE CONGESTIVE 35
263 CHRONIC SPONTANEOUS URTICARIA 35
264 CYTOKINE RELEASE SYNDROME 35
265 CYTOMEGALOVIRUS VIRAEMIA 35
266 FLUSHING 35
267 HAEMATOCRIT DECREASED 35
268 INCORRECT DOSE ADMINISTERED 35
269 PSORIASIS 35
270 RENAL TUBULAR NECROSIS 35
271 SEIZURE 35
272 UNEVALUABLE EVENT 35
273 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 35
274 ABSCESS 34
275 AGRANULOCYTOSIS 34
276 APPLICATION SITE PAIN 34
277 BLOOD LACTATE DEHYDROGENASE INCREASED 34
278 CONVULSION 34
279 SCAR 34
280 BASAL CELL CARCINOMA 33
281 KLEBSIELLA INFECTION 33
282 MYCOBACTERIUM AVIUM COMPLEX INFECTION 33
283 PRODUCT PHYSICAL CONSISTENCY ISSUE 33
284 RHEUMATOID ARTHRITIS 33
285 TOXIC EPIDERMAL NECROLYSIS 33
286 ACUTE RESPIRATORY DISTRESS SYNDROME 32
287 DRUG ERUPTION 32
288 DYSPEPSIA 32
289 HAEMATURIA 32
290 INJECTION SITE ERYTHEMA 32
291 INTENTIONAL PRODUCT MISUSE 32
292 LIVER DISORDER 32
293 PHOTOPHOBIA 32
294 BRONCHOPULMONARY ASPERGILLOSIS 31
295 DEPRESSED LEVEL OF CONSCIOUSNESS 31
296 DIVERTICULITIS 31
297 DRY EYE 31
298 MUCOSAL INFLAMMATION 31
299 PHOTOSENSITIVITY REACTION 31
300 RASH PAPULAR 31
301 SLEEP DISORDER 31
302 THERAPEUTIC RESPONSE UNEXPECTED 31
303 C-REACTIVE PROTEIN INCREASED 30
304 EPSTEIN-BARR VIRUS INFECTION 30
305 HYPOKALAEMIA 30
306 ILL-DEFINED DISORDER 30
307 NECROTISING FASCIITIS 30
308 OVERDOSE 30
309 PEMPHIGUS 30
310 QUALITY OF LIFE DECREASED 30
311 STOMATITIS 30
312 VIRAL INFECTION 30
313 BLOOD PRESSURE FLUCTUATION 29
314 FEELING HOT 29
315 HAEMATOCHEZIA 29
316 HEPATOTOXICITY 29
317 HYPERBILIRUBINAEMIA 29
318 LOWER RESPIRATORY TRACT INFECTION 29
319 MENINGITIS ASEPTIC 29
320 RECTAL HAEMORRHAGE 29
321 WHEEZING 29
322 ARTHRITIS 28
323 CARDIAC DISORDER 28
324 CROHN^S DISEASE 28
325 FULL BLOOD COUNT DECREASED 28
326 LIP SWELLING 28
327 NASAL CONGESTION 28
328 NODULE 28
329 PAIN OF SKIN 28
330 SKIN HYPERPIGMENTATION 28
331 VANISHING BILE DUCT SYNDROME 28
332 APPLICATION SITE ERYTHEMA 27
333 BLOOD UREA INCREASED 27
334 CHOLESTASIS 27
335 EOSINOPHILIA 27
336 FLUID RETENTION 27
337 INTERNATIONAL NORMALISED RATIO INCREASED 27
338 INTERSTITIAL LUNG DISEASE 27
339 MULTI-ORGAN FAILURE 27
340 RESPIRATORY DISORDER 27
341 SUICIDE ATTEMPT 27
342 BRAIN ABSCESS 26
343 COLITIS 26
344 CYST 26
345 ECZEMA 26
346 ESCHERICHIA INFECTION 26
347 EXPOSURE DURING PREGNANCY 26
348 EYE SWELLING 26
349 LUPUS-LIKE SYNDROME 26
350 PRODUCT DOSE OMISSION 26
351 PRODUCT PRESCRIBING ISSUE 26
352 ASCITES 25
353 BACTERIAL INFECTION 25
354 BLOOD POTASSIUM DECREASED 25
355 CARPAL TUNNEL SYNDROME 25
356 DRY MOUTH 25
357 HEPATOMEGALY 25
358 HIP FRACTURE 25
359 HYPOGLYCAEMIA 25
360 INFLAMMATION 25
361 INJECTION SITE SWELLING 25
362 OCULAR HYPERAEMIA 25
363 PERICARDIAL EFFUSION 25
364 STAPHYLOCOCCAL BACTERAEMIA 25
365 TRANSAMINASES INCREASED 25
366 WOUND 25
367 ADVERSE EVENT 24
368 BACTERAEMIA 24
369 BLINDNESS 24
370 DISORIENTATION 24
371 DYSGEUSIA 24
372 DYSURIA 24
373 FOETAL EXPOSURE DURING PREGNANCY 24
374 GLUCOSE TOLERANCE IMPAIRED 24
375 HEPATIC FUNCTION ABNORMAL 24
376 HYPOTHYROIDISM 24
377 NEPHROLITHIASIS 24
378 PRODUCT PHYSICAL ISSUE 24
379 PROTEINURIA 24
380 VASCULITIS 24
381 AGITATION 23
382 APHASIA 23
383 ASPERGILLUS INFECTION 23
384 BEHCET^S SYNDROME 23
385 BLOOD CHOLESTEROL INCREASED 23
386 DEPRESSED MOOD 23
387 DRUG DEPENDENCE 23
388 FLATULENCE 23
389 GASTRITIS 23
390 IMMUNE RECONSTITUTION SYNDROME 23
391 INJECTION SITE BRUISING 23
392 LYMPHADENITIS 23
393 LYMPHOPENIA 23
394 MOUTH ULCERATION 23
395 OSTEOARTHRITIS 23
396 PAPULE 23
397 PULMONARY HYPERTENSION 23
398 RENAL INJURY 23
399 SKIN PLAQUE 23
400 SUBCUTANEOUS ABSCESS 23
401 THROMBOTIC MICROANGIOPATHY 23
402 UROSEPSIS 23
403 WOUND COMPLICATION 23
404 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 22
405 ACUTE MYELOID LEUKAEMIA 22
406 ADRENAL INSUFFICIENCY 22
407 BLOOD ALBUMIN DECREASED 22
408 BONE PAIN 22
409 COELIAC DISEASE 22
410 COMA 22
411 DERMATITIS ATOPIC 22
412 DRUG TOXICITY 22
413 EYE IRRITATION 22
414 GINGIVAL BLEEDING 22
415 HAEMODIALYSIS 22
416 HYPOVOLAEMIA 22
417 IMMUNODEFICIENCY 22
418 LIVER INJURY 22
419 MUSCULOSKELETAL PAIN 22
420 PNEUMOTHORAX 22
421 SKIN ODOUR ABNORMAL 22
422 THERAPY INTERRUPTED 22
423 WOUND SECRETION 22
424 ARTHROPATHY 21
425 COGNITIVE DISORDER 21
426 DERMATITIS BULLOUS 21
427 KIDNEY TRANSPLANT REJECTION 21
428 NEUTROPENIC SEPSIS 21
429 PETECHIAE 21
430 PNEUMONIA PSEUDOMONAL 21
431 RASH GENERALISED 21
432 TACHYPNOEA 21
433 BLOOD METHAEMOGLOBIN PRESENT 20
434 DYSPHONIA 20
435 ENCEPHALITIS 20
436 INJURY 20
437 LOCALISED INFECTION 20
438 LUPUS NEPHRITIS 20
439 MALIGNANT NEOPLASM PROGRESSION 20
440 MENTAL IMPAIRMENT 20
441 PULMONARY MASS 20
442 RHINORRHOEA 20
443 SINUS DISORDER 20
444 AUTOIMMUNE HAEMOLYTIC ANAEMIA 19
445 BLOOD POTASSIUM INCREASED 19
446 BRADYCARDIA 19
447 COAGULOPATHY 19
448 CYSTITIS 19
449 DECREASED ACTIVITY 19
450 DISCOMFORT 19
451 DISTURBANCE IN ATTENTION 19
452 DRUG EFFECT INCOMPLETE 19
453 DRUG EXPOSURE DURING PREGNANCY 19
454 FLUID OVERLOAD 19
455 GLAUCOMA 19
456 LYMPHOMA 19
457 MATERNAL EXPOSURE DURING PREGNANCY 19
458 NECK PAIN 19
459 PLATELET COUNT ABNORMAL 19
460 SHOCK 19
461 STILL^S DISEASE 19
462 THROAT IRRITATION 19
463 APHTHOUS ULCER 18
464 APPLICATION SITE DISCOLOURATION 18
465 DERMATITIS EXFOLIATIVE 18
466 ENTEROCOCCAL INFECTION 18
467 EYE PAIN 18
468 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 18
469 HEART RATE DECREASED 18
470 LACTIC ACIDOSIS 18
471 LIMB INJURY 18
472 LYMPHOCYTE COUNT DECREASED 18
473 NERVOUSNESS 18
474 NEURALGIA 18
475 OBESITY 18
476 OSTEOMYELITIS 18
477 PANCREATITIS ACUTE 18
478 SPEECH DISORDER 18
479 SQUAMOUS CELL CARCINOMA 18
480 SURGERY 18
481 TASTE DISORDER 18
482 THERAPEUTIC PRODUCT INEFFECTIVE 18
483 TYPE 2 DIABETES MELLITUS 18
484 VERTIGO 18
485 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 17
486 CARDIO-RESPIRATORY ARREST 17
487 CHEILITIS 17
488 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 17
489 CORONARY ARTERY DISEASE 17
490 COVID-19 PNEUMONIA 17
491 CYTOMEGALOVIRUS TEST POSITIVE 17
492 CYTOPENIA 17
493 DYSARTHRIA 17
494 EAR INFECTION 17
495 ERYTHEMA MULTIFORME 17
496 GASTRIC DISORDER 17
497 GRANULOMA 17
498 HALLUCINATION 17
499 HEPATITIS FULMINANT 17
500 HYPOCALCAEMIA 17
501 IMMUNE THROMBOCYTOPENIA 17
502 INTERVERTEBRAL DISC DEGENERATION 17
503 KIDNEY INFECTION 17
504 MYELOSUPPRESSION 17
505 NEPHROGENIC ANAEMIA 17
506 POLLAKIURIA 17
507 PRE-EXISTING CONDITION IMPROVED 17
508 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 17
509 PULMONARY FIBROSIS 17
510 PULMONARY HAEMORRHAGE 17
511 SCRATCH 17
512 SMALL INTESTINAL OBSTRUCTION 17
513 SPINAL FRACTURE 17
514 SPLENOMEGALY 17
515 TINNITUS 17
516 TUBULOINTERSTITIAL NEPHRITIS 17
517 TYPE 1 LEPRA REACTION 17
518 ACUTE HEPATIC FAILURE 16
519 AGGRESSION 16
520 APLASIA PURE RED CELL 16
521 BLOOD IRON DECREASED 16
522 CANDIDA INFECTION 16
523 COLITIS ULCERATIVE 16
524 DIPLOPIA 16
525 DYSSTASIA 16
526 EYELID IRRITATION 16
527 GAIT INABILITY 16
528 GAMMA-GLUTAMYLTRANSFERASE INCREASED 16
529 GASTROENTERITIS 16
530 HEPATITIS B 16
531 HERPES SIMPLEX 16
532 HYPERLIPIDAEMIA 16
533 MOOD SWINGS 16
534 NECROSIS 16
535 PRESYNCOPE 16
536 PRODUCT CONTAINER ISSUE 16
537 PSYCHOTIC DISORDER 16
538 RESPIRATORY TRACT INFECTION 16
539 SKIN INFECTION 16
540 TRANSPLANT REJECTION 16
541 ABORTION SPONTANEOUS 15
542 ANOREXIA 15
543 APPLICATION SITE IRRITATION 15
544 BLOOD PRESSURE SYSTOLIC ABNORMAL 15
545 BLOOD SODIUM DECREASED 15
546 BLOOD TRIGLYCERIDES INCREASED 15
547 CEREBRAL HAEMORRHAGE 15
548 CHOLELITHIASIS 15
549 CUTANEOUS LUPUS ERYTHEMATOSUS 15
550 DIALYSIS 15
551 FACE OEDEMA 15
552 FACIAL PAIN 15
553 HYPOMAGNESAEMIA 15
554 HYPOPHAGIA 15
555 IMPAIRED WORK ABILITY 15
556 IRRITABLE BOWEL SYNDROME 15
557 LEPROMATOUS LEPROSY 15
558 MEDICATION ERROR 15
559 NEOPLASM MALIGNANT 15
560 PALLOR 15
561 PLEOCYTOSIS 15
562 RHABDOMYOLYSIS 15
563 SQUAMOUS CELL CARCINOMA OF SKIN 15
564 SUPRAVENTRICULAR TACHYCARDIA 15
565 SYNOVIAL CYST 15
566 THERAPEUTIC PRODUCT EFFECT DECREASED 15
567 TOXOPLASMOSIS 15
568 VENTRICULAR TACHYCARDIA 15
569 ACUTE MYOCARDIAL INFARCTION 14
570 ANAEMIA MACROCYTIC 14
571 ARRHYTHMIA 14
572 ATELECTASIS 14
573 BK VIRUS INFECTION 14
574 BLOOD DISORDER 14
575 BRAIN OEDEMA 14
576 CUSHING^S SYNDROME 14
577 DERMATITIS HERPETIFORMIS 14
578 DIFFUSE LARGE B-CELL LYMPHOMA 14
579 DISSEMINATED INTRAVASCULAR COAGULATION 14
580 FOOT FRACTURE 14
581 GASTRIC ULCER 14
582 HAEMOGLOBIN ABNORMAL 14
583 HAEMOPTYSIS 14
584 HEPATIC CIRRHOSIS 14
585 HYPERCALCAEMIA 14
586 INJECTION SITE PRURITUS 14
587 INSURANCE ISSUE 14
588 LIVER FUNCTION TEST INCREASED 14
589 LUNG INFECTION 14
590 MALNUTRITION 14
591 MUSCLE ATROPHY 14
592 PARADOXICAL DRUG REACTION 14
593 POOR VENOUS ACCESS 14
594 PRODUCT AVAILABILITY ISSUE 14
595 PRURITUS GENERALISED 14
596 RENAL TRANSPLANT 14
597 SKIN PAPILLOMA 14
598 THERAPY CESSATION 14
599 TORSADE DE POINTES 14
600 UNRESPONSIVE TO STIMULI 14
601 URINARY RETENTION 14
602 VISUAL ACUITY REDUCED 14
603 ZYGOMYCOSIS 14
604 ABASIA 13
605 ACIDOSIS 13
606 APPLICATION SITE DRYNESS 13
607 AZOTAEMIA 13
608 BODY TEMPERATURE INCREASED 13
609 BONE DISORDER 13
610 BONE LOSS 13
611 CUTANEOUS VASCULITIS 13
612 CYTOMEGALOVIRUS INFECTION REACTIVATION 13
613 DERMATITIS CONTACT 13
614 DIABETES MELLITUS INADEQUATE CONTROL 13
615 DISSEMINATED CRYPTOCOCCOSIS 13
616 EAR DISCOMFORT 13
617 EAR PAIN 13
618 GENERALISED OEDEMA 13
619 IMMUNOSUPPRESSION 13
620 INTENTIONAL DOSE OMISSION 13
621 IRRITABILITY 13
622 MOOD ALTERED 13
623 NEUROTOXICITY 13
624 NIGHTMARE 13
625 ORTHOSTATIC HYPOTENSION 13
626 PANIC ATTACK 13
627 PRODUCT FORMULATION ISSUE 13
628 RESPIRATORY RATE INCREASED 13
629 SKIN NECROSIS 13
630 SLEEP APNOEA SYNDROME 13
631 TENDERNESS 13
632 TOOTH DISORDER 13
633 URINARY INCONTINENCE 13
634 ABDOMINAL PAIN LOWER 12
635 ABNORMAL BEHAVIOUR 12
636 AEROMONAS INFECTION 12
637 AREFLEXIA 12
638 BLINDNESS UNILATERAL 12
639 BLOOD CREATINE PHOSPHOKINASE INCREASED 12
640 BLOOD PRESSURE DIASTOLIC DECREASED 12
641 CD4 LYMPHOCYTES DECREASED 12
642 DERMATITIS ALLERGIC 12
643 DERMATITIS EXFOLIATIVE GENERALISED 12
644 DEVICE RELATED INFECTION 12
645 EMOTIONAL DISORDER 12
646 EXPIRED PRODUCT ADMINISTERED 12
647 EYE PRURITUS 12
648 EYELID PTOSIS 12
649 GASTRIC ULCER HAEMORRHAGE 12
650 GASTROENTERITIS VIRAL 12
651 GROIN PAIN 12
652 HAEMATOMA 12
653 HEPATORENAL SYNDROME 12
654 HYPERSOMNIA 12
655 HYPERTRIGLYCERIDAEMIA 12
656 HYPOACUSIS 12
657 HYPOGAMMAGLOBULINAEMIA 12
658 IMMUNE SYSTEM DISORDER 12
659 LIPASE INCREASED 12
660 LUNG CONSOLIDATION 12
661 LUNG NEOPLASM MALIGNANT 12
662 MASS 12
663 MULTIPLE FRACTURES 12
664 MYELODYSPLASTIC SYNDROME 12
665 NEPHROPATHY TOXIC 12
666 NO THERAPEUTIC RESPONSE 12
667 NOCTURIA 12
668 PNEUMONIA CYTOMEGALOVIRAL 12
669 PNEUMONIA FUNGAL 12
670 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 12
671 PRODUCT DOSE OMISSION IN ERROR 12
672 PURULENT DISCHARGE 12
673 PUSTULE 12
674 RENAL CYST 12
675 RESPIRATORY SYNCYTIAL VIRUS INFECTION 12
676 SKIN MASS 12
677 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 12
678 SPINAL COMPRESSION FRACTURE 12
679 STEROID DEPENDENCE 12
680 VITAMIN D DEFICIENCY 12
681 ACCIDENTAL EXPOSURE TO PRODUCT 11
682 ACNE CYSTIC 11
683 ADENOVIRUS INFECTION 11
684 ANURIA 11
685 ASPIRATION 11
686 CALCIPHYLAXIS 11
687 CARDIOGENIC SHOCK 11
688 CARDIOMEGALY 11
689 COMPLETED SUICIDE 11
690 CRYING 11
691 DIABETIC KETOACIDOSIS 11
692 DRUG LEVEL ABOVE THERAPEUTIC 11
693 DYSKINESIA 11
694 ECCHYMOSIS 11
695 ESCHERICHIA BACTERAEMIA 11
696 EYE DISORDER 11
697 FAILURE TO THRIVE 11
698 FISTULA 11
699 GENERALISED TONIC-CLONIC SEIZURE 11
700 GLOMERULONEPHRITIS 11
701 HAEMODYNAMIC INSTABILITY 11
702 HOT FLUSH 11
703 HYDROCEPHALUS 11
704 INJECTION SITE URTICARIA 11
705 INTESTINAL OBSTRUCTION 11
706 JARISCH-HERXHEIMER REACTION 11
707 JUGULAR VEIN THROMBOSIS 11
708 LACRIMATION INCREASED 11
709 LEUKAEMOID REACTION 11
710 LEUKOENCEPHALOPATHY 11
711 MYASTHENIA GRAVIS 11
712 OCULAR ICTERUS 11
713 ONYCHOMADESIS 11
714 PARALYSIS 11
715 PLATELET COUNT INCREASED 11
716 PNEUMOMEDIASTINUM 11
717 PNEUMONIA BACTERIAL 11
718 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 11
719 RHINOVIRUS INFECTION 11
720 SKIN CANCER 11
721 SKIN SWELLING 11
722 STEM CELL TRANSPLANT 11
723 SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS 11
724 WHITE BLOOD CELL COUNT ABNORMAL 11
725 ACCIDENTAL POISONING 10
726 ACTIVITIES OF DAILY LIVING IMPAIRED 10
727 ALOPECIA SCARRING 10
728 ANKLE FRACTURE 10
729 AUTOIMMUNE DISORDER 10
730 BLOOD CREATININE ABNORMAL 10
731 BLOOD MAGNESIUM DECREASED 10
732 BONE DEMINERALISATION 10
733 CANDIDIASIS 10
734 CENTRAL OBESITY 10
735 CHROMATURIA 10
736 CYTOMEGALOVIRUS CHORIORETINITIS 10
737 DIZZINESS POSTURAL 10
738 DRUG EFFECT LESS THAN EXPECTED 10
739 EOSINOPHIL COUNT INCREASED 10
740 FANCONI SYNDROME ACQUIRED 10
741 FEAR 10
742 FEMUR FRACTURE 10
743 FIBROMYALGIA 10
744 FOETAL GROWTH RESTRICTION 10
745 FOOT DEFORMITY 10
746 GANGRENE 10
747 HAEMORRHAGE INTRACRANIAL 10
748 HEPATIC NECROSIS 10
749 HERPES VIRUS INFECTION 10
750 HYPOAESTHESIA ORAL 10
751 HYPOPHOSPHATAEMIA 10
752 INFECTION REACTIVATION 10
753 INJECTION SITE HAEMORRHAGE 10
754 INTERVERTEBRAL DISC PROTRUSION 10
755 IRON DEFICIENCY ANAEMIA 10
756 JOINT RANGE OF MOTION DECREASED 10
757 MULTIPLE MYELOMA 10
758 NEOPLASM PROGRESSION 10
759 NEPHRITIS 10
760 NEPHROGENIC SYSTEMIC FIBROSIS 10
761 NERVOUS SYSTEM DISORDER 10
762 OESOPHAGEAL ULCER 10
763 OESOPHAGITIS 10
764 OSTEONECROSIS OF JAW 10
765 POLYARTHRITIS 10
766 POST PROCEDURAL COMPLICATION 10
767 PREGNANCY 10
768 PULMONARY CONGESTION 10
769 PURPURA 10
770 RIB FRACTURE 10
771 ROSACEA 10
772 SARS-COV-2 TEST POSITIVE 10
773 SEBORRHOEA 10
774 SKIN FISSURES 10
775 SKIN INDURATION 10
776 STREPTOCOCCAL INFECTION 10
777 SWOLLEN TONGUE 10
778 THROAT TIGHTNESS 10
779 TOOTHACHE 10
780 UPPER-AIRWAY COUGH SYNDROME 10
781 URTICARIAL VASCULITIS 10
782 VENTRICULAR FIBRILLATION 10
783 ABNORMAL DREAMS 9
784 AGEUSIA 9
785 APLASTIC ANAEMIA 9
786 APPLICATION SITE EXFOLIATION 9
787 APPLICATION SITE PRURITUS 9
788 BACTERIAL SEPSIS 9
789 BIPOLAR DISORDER 9
790 BLOOD COUNT ABNORMAL 9
791 BLOOD CULTURE POSITIVE 9
792 BLOOD GLUCOSE DECREASED 9
793 BLOOD PHOSPHORUS INCREASED 9
794 BRAIN FOG 9
795 BRAIN INJURY 9
796 BREAST CANCER 9
797 CEREBRAL ISCHAEMIA 9
798 CEREBRAL TOXOPLASMOSIS 9
799 CHRONIC GRAFT VERSUS HOST DISEASE 9
800 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 9
801 CHRONIC LYMPHOCYTIC LEUKAEMIA 9
802 COMPUTERISED TOMOGRAM THORAX ABNORMAL 9
803 COORDINATION ABNORMAL 9
804 CRYOGLOBULINAEMIA 9
805 CYTOMEGALOVIRUS COLITIS 9
806 DEAFNESS 9
807 DIFFUSE ALVEOLAR DAMAGE 9
808 DISSEMINATED TUBERCULOSIS 9
809 DRUG EFFECT DECREASED 9
810 EYE INFLAMMATION 9
811 HEPATIC STEATOSIS 9
812 HERNIA 9
813 HYPERPARATHYROIDISM SECONDARY 9
814 ILEUS 9
815 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 9
816 IMPAIRED GASTRIC EMPTYING 9
817 INDURATION 9
818 INJECTION SITE RASH 9
819 ISCHAEMIC STROKE 9
820 LEPROSY 9
821 LOCAL SWELLING 9
822 LUNG ABSCESS 9
823 LYME DISEASE 9
824 LYMPHOCYTE COUNT INCREASED 9
825 MARROW HYPERPLASIA 9
826 MELAENA 9
827 MENINGITIS 9
828 MUSCLE STRAIN 9
829 MUSCLE TWITCHING 9
830 NORMOCYTIC ANAEMIA 9
831 OESOPHAGEAL CANDIDIASIS 9
832 OLIGURIA 9
833 ORAL DISORDER 9
834 PAIN IN JAW 9
835 PARANOIA 9
836 PERSONALITY CHANGE 9
837 PIGMENTATION DISORDER 9
838 PREMATURE BABY 9
839 PROTEIN TOTAL DECREASED 9
840 PSEUDOMONAL SEPSIS 9
841 PSORIATIC ARTHROPATHY 9
842 PYELONEPHRITIS 9
843 RASH PUSTULAR 9
844 RED BLOOD CELL SEDIMENTATION RATE INCREASED 9
845 RESPIRATORY TRACT CONGESTION 9
846 RETINAL DETACHMENT 9
847 SKIN CANDIDA 9
848 SKIN HAEMORRHAGE 9
849 SKIN HYPOPIGMENTATION 9
850 SKIN TIGHTNESS 9
851 SNEEZING 9
852 STEROID DIABETES 9
853 STRONGYLOIDIASIS 9
854 SUPERINFECTION BACTERIAL 9
855 TENDON RUPTURE 9
856 THIRST 9
857 TOOTH ABSCESS 9
858 TOOTH LOSS 9
859 TRANSFUSION 9
860 TUBERCULOID LEPROSY 9
861 UPPER LIMB FRACTURE 9
862 VIRAEMIA 9
863 ABNORMAL WEIGHT GAIN 8
864 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 8
865 ADVERSE REACTION 8
866 ANGER 8
867 AUTOINFLAMMATORY DISEASE 8
868 BLOOD AMYLASE INCREASED 8
869 BLOOD LACTIC ACID INCREASED 8
870 BLOOD PRESSURE SYSTOLIC DECREASED 8
871 BLOOD TEST ABNORMAL 8
872 BONE MARROW TOXICITY 8
873 BONE MARROW TRANSPLANT 8
874 BRONCHIOLITIS 8
875 CARDIOMYOPATHY 8
876 CEREBRAL ASPERGILLOSIS 8
877 CEREBRAL INFARCTION 8
878 CLOSTRIDIAL INFECTION 8
879 COMPLICATIONS OF TRANSPLANTED KIDNEY 8
880 CONJUNCTIVITIS 8
881 CORNEAL PERFORATION 8
882 DEMENTIA 8
883 DERMATITIS ACNEIFORM 8
884 DEVICE MALFUNCTION 8
885 DRUG LEVEL INCREASED 8
886 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 8
887 ELECTROCARDIOGRAM QT PROLONGED 8
888 EMBOLISM 8
889 EMPHYSEMA 8
890 ERECTILE DYSFUNCTION 8
891 ESSENTIAL HYPERTENSION 8
892 EYE INFECTION 8
893 EYE MOVEMENT DISORDER 8
894 EYELID OEDEMA 8
895 FAECALOMA 8
896 FLUID IMBALANCE 8
897 FOLLICULITIS 8
898 FOREIGN BODY IN THROAT 8
899 GASTROINTESTINAL INFECTION 8
900 GOUT 8
901 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 8
902 GRAFT VERSUS HOST DISEASE IN SKIN 8
903 GRANULOMATOUS LIVER DISEASE 8
904 HAEMATEMESIS 8
905 HAEMATOTOXICITY 8
906 HAND FRACTURE 8
907 HEAD INJURY 8
908 HEMIPARESIS 8
909 HENOCH-SCHONLEIN PURPURA 8
910 HEPATITIS ACUTE 8
911 HEPATITIS TOXIC 8
912 HEREDITARY ANGIOEDEMA 8
913 HIV ASSOCIATED NEPHROPATHY 8
914 HIV INFECTION 8
915 HYPOALBUMINAEMIA 8
916 IDIOPATHIC PNEUMONIA SYNDROME 8
917 INCONTINENCE 8
918 INCREASED APPETITE 8
919 INFUSION SITE PAIN 8
920 JC VIRUS INFECTION 8
921 JOINT STIFFNESS 8
922 KAPOSI'S SARCOMA 8
923 LIBIDO DECREASED 8
924 LUNG TRANSPLANT REJECTION 8
925 LYMPHOCYTIC INFILTRATION 8
926 LYMPHOCYTOSIS 8
927 MICTURITION URGENCY 8
928 MUCOCUTANEOUS LEISHMANIASIS 8
929 MULTIPLE-DRUG RESISTANCE 8
930 MUSCULOSKELETAL CHEST PAIN 8
931 MYCOBACTERIAL INFECTION 8
932 MYCOBACTERIUM ABSCESSUS INFECTION 8
933 MYOSITIS 8
934 NEPHROPATHY 8
935 NEURITIS 8
936 NEUTROPHIL COUNT INCREASED 8
937 ONYCHOCLASIS 8
938 ORAL MUCOSAL BLISTERING 8
939 PANCREATIC DISORDER 8
940 PHARYNGOLARYNGEAL PAIN 8
941 PLASMA CELL MYELOMA RECURRENT 8
942 PLATELET TRANSFUSION 8
943 PNEUMONIA CRYPTOCOCCAL 8
944 POSTOPERATIVE WOUND INFECTION 8
945 PROCEDURAL PAIN 8
946 PRODUCT STORAGE ERROR 8
947 PULMONARY CAVITATION 8
948 RESTLESSNESS 8
949 SEASONAL ALLERGY 8
950 SECRETION DISCHARGE 8
951 SERUM AMYLOID A PROTEIN INCREASED 8
952 SKIN LACERATION 8
953 SKIN WARM 8
954 SPINAL OSTEOARTHRITIS 8
955 SUSPECTED OFF LABEL USE 8
956 SYSTEMIC CANDIDA 8
957 THERAPEUTIC PRODUCT CROSS-REACTIVITY 8
958 THERAPEUTIC RESPONSE SHORTENED 8
959 TUBERCULOSIS 8
960 URINARY TRACT INFECTION ENTEROCOCCAL 8
961 VENOOCCLUSIVE DISEASE 8
962 VIRAL LOAD INCREASED 8
963 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 7
964 AFFECTIVE DISORDER 7
965 ALANINE AMINOTRANSFERASE ABNORMAL 7
966 AMMONIA INCREASED 7
967 ANAEMIA HEINZ BODY 7
968 ANAEMIA OF CHRONIC DISEASE 7
969 ANGINA PECTORIS 7
970 ANTICOAGULATION DRUG LEVEL BELOW THERAPEUTIC 7
971 AORTIC ANEURYSM 7
972 APHONIA 7
973 APPLICATION SITE RASH 7
974 APRAXIA 7
975 ARTHRITIS BACTERIAL 7
976 BLOOD HIV RNA INCREASED 7
977 BLOOD PHOSPHORUS DECREASED 7
978 BLOOD PRESSURE ABNORMAL 7
979 BLOOD PRESSURE DIASTOLIC ABNORMAL 7
980 BLOOD PRESSURE DIASTOLIC INCREASED 7
981 BLOOD URINE PRESENT 7
982 BODY TEMPERATURE DECREASED 7
983 CARDIOVASCULAR DISORDER 7
984 CHRONIC GASTRITIS 7
985 CHRONIC MYELOMONOCYTIC LEUKAEMIA 7
986 CYANOSIS CENTRAL 7
987 DENTAL CARIES 7
988 DEVICE ISSUE 7
989 DEVICE LEAKAGE 7
990 DISABILITY 7
991 ELECTROLYTE IMBALANCE 7
992 ENURESIS 7
993 EOSINOPHILIC MYOCARDITIS 7
994 EXTRA DOSE ADMINISTERED 7
995 EYE HAEMORRHAGE 7
996 FEEDING DISORDER 7
997 FEELING COLD 7
998 FEELING JITTERY 7
999 FIBROSIS 7